Navigation Links
Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
Date:8/4/2008

SAN FRANCISCO, Aug. 4 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that it will host a teleconference and webcast with management to discuss second quarter 2008 progress and provide a general business update on Monday, August 11, 2008, at 4:30 p.m. Eastern time. A financial results press release for the second quarter ended June 30, 2008 will be released after markets close on August 11, 2008.

Interested parties may call 877-397-0286 from the U.S. or +1-719-325-4901 internationally. Individuals interested in listening to the live call via webcast may do so by visiting http://www.medivation.com. A replay of the webcast will be available on the Company's website for 30 days.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzheimer's disease and a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also known as hormone-refractory) prostate cancer. Medivation recently announced that it plans to continue further development of Dimebon in patients with mild-to-moderate Huntington's disease based on the positive results seen in its Phase 2 trial. For more information, please visit us at http://www.medivation.com.


'/>"/>
SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
2. Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
4. Medivation Announces Senior Management Promotions
5. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
6. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Research and Markets  has announced the addition of the ... report to their offering. This report ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Asia-Pacific , and Rest of ... 2012 through 2020. Market data and analytics are derived from ...
(Date:8/19/2014)... Aug. 19, 2014 Research ... of the "Spectroscopy Equipment and Accessories ... to their offering. This ... Equipment and Accessories in US$ Thousands by ... spectrophotometers, Raman Spectrometers, NMR-EPR Spectrometers, Near Infrared ...
(Date:8/19/2014)... Md. , Aug. 19, 2014   ... biotechnology company developing novel anti-infective biologic and drug ... and diseases, announced today that its novel ... at the 54 th Interscience Conference on ... Washington D.C. ...
(Date:8/18/2014)... Dallas, Texas (PRWEB) August 19, 2014 ... China Linalool Industryā€¯ is a professional and in-depth ... report provides basic Linalool information, including its ... well as industry overview. This research covers the ... well as global industry analysis covering macroeconomic environment ...
Breaking Biology Technology:Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4
... ANNAPOLIS, Md., May 7 /PRNewswire-FirstCall/ -- PharmAthene, ... company developing medical countermeasures against biological and chemical threats, ... quarter of 2009 will be released on Thursday, May ... to discuss its first quarter 2009 financial results. ...
... fuels provider New Generation Biofuels Holdings, Inc. (Nasdaq: ... has signed a contract with the City of Baltimore, Maryland,("the ... for boiler applications in the heart of Baltimore. This is ... non fossil fuel in its industrial boilers. In this program, ...
... May 7 Covance Inc. (NYSE: CVD ... its board of directors. Mr. McCartney currently serves as ... provider of specialty products, services, and supply chain solutions. ... of U.S. Robotics (USR), a multibillion dollar provider of ...
Cached Biology Technology:City of Baltimore to Evaluate New Generation Biofuels for Use in Boiler Applications 2City of Baltimore to Evaluate New Generation Biofuels for Use in Boiler Applications 3Covance Elects John McCartney to Company's Board of Directors 2
(Date:8/19/2014)... Plants are superior to humans and animals in a ... regenerate, which enables them to regrow entire organs. After ... grow back its entire crown. But there is one ... quite literally rooted to the habitats in which they ... elements. In response to this dilemma, plants have developed ...
(Date:8/19/2014)... to treat pain, but its effect on pain ... a recent study reported on the Neural ... rat models of an avulsion injury to the ... neuropathic pain) were given electroacupuncture stimulation at bilateral ... (GB34). After electroacupuncture therapy, chronic neuropathic pain in ...
(Date:8/19/2014)... news release is available in German . ... get new information about the metabolism of plants can ... However, Erich Kombrink from the Max Planck Institute for ... the University of Duisburg-Essen adopt a different approach. They ... metabolic process like brake pads and prevent the downstream ...
Breaking Biology News(10 mins):How steroid hormones enable plants to grow 2Researchers block plant hormone 2Researchers block plant hormone 3
... cases of Marburg haemorrhagic fever have been reported in ... reported its first 6 cases, bringing the number of ... part of the country. , Mobile surveillance teams in ... were attacked and damaged by local residents. As the ...
... provide a method of quantifying the expression and order of ... measure of cell physiology, said researchers at Baylor College of ... journal Nature Genetics. , "Microarray data are good phenotypes to ... measure of cell status," said Dr. Gad Shaulsky, associate professor ...
... administration to improve patient compliance and reduce drug side ... healthcare product category. While quietly gaining market share for ... and HRT, the technology is set to make further ... conditions wind their way through the development and clinical ...
Cached Biology News:WHO suspends Marburg work, appeals for new funds 2Microarrays as phenotype 2
CELLine System cultivation flask (for secreted products)...
... incubation trays are disposable trays ... antigens that have been blotted ... has eight 10.5 cm x ... strips cut from blotted membrane ...
... The ProteoPrep 20 Plasma Immunodepletion Kit specifically ... from human plasma or serum in preparation ... deeper penetration into the plasma proteome whether ... or multidimensional chromatography or go straight to ...
... the industry's first siRNA sequence design software ... keep these tools consistent with new experimental ... field of RNAi. With the introduction ... design tools, OligoEngine is pleased to offer ...
Biology Products: